Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
laikubicin
- Development stage
- Unknown
- Lead developer
- Qinli
- Modality
- Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intravenous
01
Overview
Laikubicin is an investigational anticancer drug being developed as an injectable formulation. It is currently undergoing clinical trials to assess its efficacy and safety compared to doxorubicin hydrochloride for injection, a well-established anthracycline chemotherapy agent. The primary objective of ongoing studies is to determine whether laikubicin offers non-inferior or superior outcomes relative to doxorubicin in cancer treatment. While detailed mechanistic data are not available, the context suggests that laikubicin may function similarly to other anthracyclines, potentially acting as a DNA intercalator and topoisomerase II inhibitor, thereby disrupting cancer cell replication[1].
- Other names
- laikubicin
Beyond the preview
Go deeper on laikubicin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on laikubicin.